Novel Biomarker Genes for Prognosis of Survival and Treatment of Glioma

Glioblastoma multiforme (GBM) is the most aggressive malignant primary central nervous system tumor. Although surgery, radiotherapy, and chemotherapy treatments are available, the 5-year survival rate of GBM is only 5.8%. Therefore, it is imperative to find novel biomarker for the prognosis and trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiaopeng, Pan, Sian, Li, Rui, Chen, Zebo, Xie, Xingyun, Han, Deqing, Lv, Shengqing, Huang, Yongkai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714878/
https://www.ncbi.nlm.nih.gov/pubmed/34976783
http://dx.doi.org/10.3389/fonc.2021.667884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714878/
https://www.ncbi.nlm.nih.gov/pubmed/34976783
http://dx.doi.org/10.3389/fonc.2021.667884

Ejemplares similares